In a move that allows it to deliver prescriptions to customer homes nationwide, Amazon (NASDAQ:AMZN) is acquiring PillPack for an undisclosed sum that TechCrunch reports approached $1 billion. The acquisition comes years after Amazon sold off its interest in drugstore.com, a now-shuttered online pharmacy that emerged during the dot-com era, and about one year after rumors emerged that it was considering entering the pharmacy marketplace.
Pharmacy benefit managers (PBMs), including Express Scripts (NASDAQ:ESRX), and pharmacy retailers, including Walgreens Boots Alliance (NASDAQ:WBA) and CVS Health (NYSE:CVS), sold off sharply on the PillPack acquisition news. But is this deal as bad for these companies as it seems?
Disrupting A Massive Market
Amazon has already said that it's creating an internal PBM to serve its 128,000 employees. And it announced that it's teaming up with JPMorgan Chase and Warren Buffett's Berkshire Hathaway to form a nonprofit, in hopes of reinventing the broader healthcare system.
Hot Warren Buffett Stocks To Invest In 2019: Coherent, Inc.(COHR)
Advisors' Opinion:- [By Joseph Griffin]
Hood River Capital Management LLC decreased its position in shares of Coherent, Inc. (NASDAQ:COHR) by 63.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 69,773 shares of the scientific and technical instruments company’s stock after selling 122,518 shares during the quarter. Hood River Capital Management LLC owned about 0.28% of Coherent worth $13,075,000 as of its most recent SEC filing.
- [By Ethan Ryder]
Earnest Partners LLC lifted its stake in shares of Coherent, Inc. (NASDAQ:COHR) by 2.2% during the 1st quarter, Holdings Channel reports. The firm owned 453,873 shares of the scientific and technical instruments company’s stock after buying an additional 9,868 shares during the quarter. Earnest Partners LLC’s holdings in Coherent were worth $85,056,000 as of its most recent SEC filing.
- [By ]
Coherent, Inc. (NASDAQ:COHR) is one of the oldest companies in the laser technology space based in California, US. The company employs around 5,218 employees and has grown rapidly in terms of revenues as well as profits over the past few years. A recent sell-off as a result of forex risks and a negative market sentiment with respect to lasers has brought the stock price down to reasonable valuations. However, analysts continue to remain bullish on the stock with target prices showing a minimum appreciation of 40% over the current market price.
- [By Ezra Schwarzbaum]
Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:
Lumentum Holdings Inc (NASDAQ: LITE) Ciena Corporation (NYSE: CIEN) Coherent, Inc. (NASDAQ: COHR) II-VI, Inc. (NASDAQ: IIVI) Inphi Corporation (NYSE: IPHI) Skyworks Solutions Inc (NASDAQ: SWKS) Integrated Device Technology Inc (NASDAQ: IDTI) Qorvo Inc (NASDAQ: QRVO) Xilinx, Inc. (NASDAQ: XLNX) Broadcom Inc (NASDAQ: AVGO)Related Links:
Hot Warren Buffett Stocks To Invest In 2019: Aimmune Therapeutics, Inc.(AIMT)
Advisors' Opinion:- [By Chris Lange]
Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed trading most recently at $37.20, with a consensus price target of $57.11 and a 52-week range of $15.97 to $40.65.
- [By Shane Hupp]
Aimmune Therapeutics (NASDAQ:AIMT)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued to clients and investors on Wednesday. They currently have a $72.00 target price on the biotechnology company’s stock. Wedbush’s price objective points to a potential upside of 117.59% from the company’s previous close.
- [By Chris Lange]
Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.
- [By ]
Aimmune Therapeutics (AIMT) : "I do like it. That's an important niche business. "
Ingersoll-Rand (IR) : "I like Ingersoll-Rand. They work well at this phase in the cycle."
Hot Warren Buffett Stocks To Invest In 2019: Beazer Homes USA, Inc.(BZH)
Advisors' Opinion:- [By Joseph Griffin]
Shares of Beazer Homes USA, Inc. (NYSE:BZH) dropped 5.9% during mid-day trading on Wednesday . The company traded as low as $14.95 and last traded at $15.02. Approximately 582,100 shares traded hands during trading, an increase of 3% from the average daily volume of 566,087 shares. The stock had previously closed at $15.96.
- [By Tyler Crowe]
Unfortunately, investors in Beazer Homes (NYSE:BZH)�haven't been reaping the benefits of this booming market, as its stock is actually down over this time frame. What exactly has kept Beazer from enjoying the fruits of a robust housing market? Let's look at the company's most recent earnings report.�
- [By Stephan Byrd]
Beazer Homes USA (NYSE:BZH) – Wedbush raised their FY2018 earnings per share (EPS) estimates for shares of Beazer Homes USA in a research note issued to investors on Thursday, May 3rd. Wedbush analyst J. Mccanless now forecasts that the construction company will post earnings per share of $2.07 for the year, up from their previous estimate of $1.75. Wedbush currently has a “Outperform” rating and a $22.00 target price on the stock. Wedbush also issued estimates for Beazer Homes USA’s Q4 2018 earnings at $1.00 EPS and Q2 2019 earnings at $0.32 EPS.
- [By Shane Hupp]
Beazer Homes USA (NYSE:BZH) was down 6% during mid-day trading on Tuesday . The stock traded as low as $14.27 and last traded at $14.38. Approximately 672,285 shares were traded during trading, an increase of 12% from the average daily volume of 601,101 shares. The stock had previously closed at $15.29.
Hot Warren Buffett Stocks To Invest In 2019: Trimble Navigation Limited(TRMB)
Advisors' Opinion:- [By Ethan Ryder]
Trimble (NASDAQ: TRMB) and Faro Technologies (NASDAQ:FARO) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.
- [By Shane Hupp]
Trimble (NASDAQ:TRMB) was downgraded by Goldman Sachs Group from a “conviction-buy” rating to a “buy” rating in a research note issued on Wednesday, The Fly reports.
- [By Logan Wallace]
Trimble (NASDAQ: TRMB) and Image Sensing Systems (NASDAQ:ISNS) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.
- [By Shane Hupp]
Neuberger Berman Group LLC cut its position in shares of Trimble Inc. (NASDAQ:TRMB) by 0.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 646,355 shares of the scientific and technical instruments company’s stock after selling 4,136 shares during the quarter. Neuberger Berman Group LLC’s holdings in Trimble were worth $23,200,000 at the end of the most recent reporting period.
- [By Lisa Levin]
Companies Reporting After The Bell Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion. International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million. Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million. General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million. Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million. Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million. Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million. National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion. The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million. Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion. Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million. AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion. Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion. Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million. Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39
Hot Warren Buffett Stocks To Invest In 2019: Wabash National Corporation(WNC)
Advisors' Opinion:- [By Logan Wallace]
Get a free copy of the Zacks research report on Wabash National (WNC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Tyler Crowe]
It wasn't that long ago that concerns about a downturn in the truck trailer business had investors concerned that Wabash National's (NYSE:WNC) best days were behind it. Those concerns seem to have been overblown, though, as demand for Wabash's products were high enough for management to raise its sales guidance for the year.�
- [By Logan Wallace]
Get a free copy of the Zacks research report on Wabash National (WNC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Wabash National (WNC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot Warren Buffett Stocks To Invest In 2019: Invesco High Income Trust II(VLT)
Advisors' Opinion:- [By Shane Hupp]
Veltor (VLT) uses the hashing algorithm. Its launch date was August 12th, 2016. Veltor’s total supply is 554,855 coins. Veltor’s official Twitter account is @j_veltor.
- [By Stephan Byrd]
Veltor (CURRENCY:VLT) traded down 0.3% against the dollar during the 1-day period ending at 21:00 PM Eastern on June 1st. In the last week, Veltor has traded down 0.1% against the dollar. Veltor has a total market capitalization of $35,706.00 and approximately $0.00 worth of Veltor was traded on exchanges in the last day. One Veltor coin can now be purchased for approximately $0.0644 or 0.00000860 BTC on major cryptocurrency exchanges.
No comments:
Post a Comment